Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

473
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
473
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

589
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
589
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

254
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
254
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

479
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
479
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

506
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
506
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

588
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
588

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protection or Vulnerability? The Context-Dependent Memory of Intestinal Inflammation.

Cellular and molecular gastroenterology and hepatology·2026
Same author

Miniature bioreactor arrays for modeling functional and structural dysbiosis in inflammatory bowel disease.

Gut microbes·2025
Same author

IL-15 Promotes Inflammatory Th17 Cells in the Intestine.

Inflammatory bowel diseases·2025
Same author

Transmission of maternal oral pathobionts to the infant gut predisposes offspring to exacerbated enteritis.

Cell reports·2025
Same author

Miniature bioreactor arrays for modeling functional and structural dysbiosis in inflammatory bowel disease.

bioRxiv : the preprint server for biology·2025
Same author

Adherent-invasive <i>Escherichia coli</i> in Crohn's disease: the 25th anniversary.

Gut·2025

Related Experiment Video

Updated: Nov 3, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.0K

Diet-Microbiota Interactions in Inflammatory Bowel Disease.

Kohei Sugihara1, Nobuhiko Kamada1

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

Nutrients
|June 2, 2021
PubMed
Summary

Diet and gut microbiota interactions are crucial for intestinal health. Understanding these connections in inflammatory bowel disease (IBD) can lead to better nutritional treatments and therapeutic strategies.

Keywords:
diet–microbiota interactionsgut microbiotainflammatory bowel disease (IBD)metabolic reprogrammingprecision nutrition

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.1K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.9K

Related Experiment Videos

Last Updated: Nov 3, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.0K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.1K
An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
07:15

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota

Published on: July 31, 2019

9.9K

Area of Science:

  • Gastroenterology and Nutrition Science
  • Microbiome Research
  • Inflammatory Bowel Disease (IBD) Pathogenesis

Background:

  • Inflammatory bowel disease (IBD) is a chronic gastrointestinal inflammatory condition with largely unknown causes.
  • Diet significantly influences gut microbiota composition, which is vital for maintaining intestinal homeostasis.
  • Intestinal inflammation in IBD can lead to gut dysbiosis, impacting nutrient utilization by host cells and microbiota.

Purpose of the Study:

  • To review current knowledge on the interaction between diet and gut microbiota in maintaining intestinal homeostasis.
  • To discuss how alterations in diet-gut microbiota interactions affect IBD outcomes and nutritional management.
  • To highlight the importance of understanding these complex relationships for IBD pathogenesis and therapeutic development.

Main Methods:

  • Literature review of existing research on diet, gut microbiota, and IBD.
  • Analysis of the bidirectional relationship between dietary factors and microbial communities in the gut.
  • Examination of how these interactions are dysregulated in the context of IBD.

Main Results:

  • Diet composition critically shapes the gut microbiota, influencing intestinal health.
  • IBD is characterized by a perturbed interaction between diet and gut microbiota, leading to dysbiosis.
  • Altered diet-microbiota dynamics in IBD impact disease progression and response to nutritional interventions.

Conclusions:

  • The interplay between diet and gut microbiota is fundamental to intestinal homeostasis and is disrupted in IBD.
  • Understanding these interactions offers critical insights into IBD pathogenesis.
  • Targeting the diet-gut microbiota axis presents promising avenues for novel therapeutic and nutritional strategies in IBD management.